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Abstract
Background: Specialized drug shops (SDSs) are popular in Sub-Saharan Africa because they provide convenient
access to medicines. There is increasing interest in how policymakers can work with them, but little knowledge on
how their operation relates to regulatory frameworks. This study sought to describe characteristics and predictors of
regulatory practices among SDSs in Kenya.
Methods: The regulatory framework governing the Kenya pharmaceutical sector was mapped, and a list of
regulations selected for inclusion in a survey questionnaire. An SDS census was conducted, and survey data
collected from 213 SDSs from two districts in Western Kenya.
Results: The majority of SDSs did not comply with regulations, with only 12% having a refrigerator and 22% having
a separate dispensing area for instance. Additionally, less than half had at least one staff with pharmacy qualification
(46%), with less than a third of all interviewed operators knowing the name of the law governing pharmacy.
Regulatory infringement was more common among SDSs in rural locations; those that did not have staff with
pharmacy qualifications; and those whose operator did not know the name of the pharmacy law. Compliance was
not significantly associated with the frequency of inspections, with over 80% of both rural and urban SDSs
reporting an inspection in the past year.
Conclusion: While compliance was low overall, it was particularly poor among SDSs operating in rural locations,
and those that did not have staff with pharmacy qualification. This suggested the need for policy to introduce
levels of practice in recognition of the variations in resource availability. Under such a system, rural SDSs operating
in low-resource setting, and selling a limited range of medicines, may be exempted from certain regulatory
requirements, as long as their scope of practice is limited to certain essential services only. Future research should
also explore why regulatory compliance is poor despite regular inspections.
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Background
Specialized drug shops (SDSs) are key players in provid-
ing access to medicines and other health services in de-
veloping countries. Their influence is reflected in the
growing interest to include them in the provision of essen-
tial services, including treatment of malaria [1,2], diarrhea
[3], respiratory tract infections [4], and non-infectious dis-
eases such as hypertension and dyslipidemia [5,6]. The
term ‘specialized drug shops’ refers to shops that sell med-
icines and related commodities [7]. The scope of SDSs
varies across countries, but will usually include registered
and unregistered pharmacies and drug shops [8]. Because
SDSs are a component of the health care system, they are
governed by regulations in ways that are similar to other
health service providers.
Regulation of private health providers prescribes mini-
mum entry conditions, quality standards, and operational
requirements [9,10]. For SDSs, regulations typically out-
line personnel qualification requirements, structural de-
sign features for the premises, minimum equipment and
* Correspondence: frankfula@yahoo.com
1KEMRI/Wellcome Trust Research Programme, P. O. Box 43640–00100,
Nairobi, Kenya
Full list of author information is available at the end of the article
© 2014 Wafula et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Wafula et al. BMC Health Services Research 2014, 14:394
http://www.biomedcentral.com/1472-6963/14/394
material requirements, and provisions for good medicine
storage and dispensing practices [11-13]. However, studies
have shown SDSs to be poor regulatory compliers in de-
veloping countries. Among the unlawful practices re-
ported are the sale of unauthorized medicines, dispensing
without prescription, and failing to comply with require-
ments for personnel and premises [14-16]. Such regulatory
infringements can affect quality of care and possibly even
endanger the lives of clients, thus undermining the public
health importance of SDSs.
In Kenya the main legislation governing the retail
pharmaceutical sector is the Pharmacy and Poisons Act of
1959, though several other regulations are also relevant
(Table 1) Table 2 summarizes key regulatory provision in
the retail sector.
Regulation is overseen by the Pharmacy and Poisons
Board (PPB), Kenya’s medicines regulatory authority.
Regulations are enforced by pharmaceutical inspectors
and public health officers (PHOs), whereas enforcement
of professional ethics is overseen by the professional
bodies representing pharmacists (degree holders) and
pharmaceutical technologists (diploma holders). Regula-
tions are accompanied by penalties for non-compliers,
ranging from fines and suspension to prison sentences.
In Kenya, only SDSs operated by registered pharmacists
or pharmaceutical technologists are recognized by law.
Both cadres are allowed to dispense prescription only
medicines and over the counter medicines. However, it
is widely known that a large proportion of SDSs are not
operated by the two cadres; for this reason, we use the
term SDSs to refer to pharmacies that are operated by
qualified and unqualified personnel.
SDSs rank among the largest category of health ser-
vice providers in Kenya. In 2008 there were roughly
5,300 public health facilities [17], while the number of
licensed and unlicensed SDSs was estimated at about
6,000 [18]. Previous studies have shown that 26 - 69%
of the Kenyan population visit retailers as the first
point of contact for common illnesses such as fever
[19-22].
Although studies have raised concern over the quality of
services provided by pharmacies in Kenya [18,23,24], there
is a lack of evidence on the relationship between regulation
on paper and practices among licensed and unlicensed
SDSs. Understanding this relationship is important both in
terms of the public health implications of regulatory non-
compliance, and in understanding the regulatory environ-
ment and likely implications for relationships between
inspectors and SDS. This study sought to document levels
of compliance with selected regulations, and to identify risk
factors for non-compliance.
Methods
Study sites and population
Data were collected in 2 districts from the western re-
gion of Kenya; Bungoma South and Kakamega Central
(Figure 1). The two are among the most densely popu-
lated districts in Kenya, with a population density of 602
(Bungoma) and 723 (Kakamega) people per km2, against a
national average of 68 [25,26]. These districts were selected
as SDSs were known to be numerous in the Western Re-
gion, and therefore of high policy importance. Both districts
also have urban and rural settings, allowing comparison of
outcomes by location.
Table 1 Rules and regulations governing the retail pharmaceutical sector in Kenya
Legislation/regulation/rule Main purpose Front-line enforcers
The Pharmacy and Poisons Act (Cap 244) Govern pharmacy profession, and manufacture,
supply and use of medicines
Pharmaceutical inspectors
The Public Health Act Govern all aspects of public health,
including medicines
Public health officers
The Food, Drugs and
Chemical Substances Act
Ensure safe provision of foods, drugs
and chemical substances
Public health officers
The Local Government Act Govern local authorities, including licensing
local service providers
Local council inspectors
The Narcotic Drugs and Psychotropic
Substances Act
Control possession and trafficking of
narcotic drugs and psychotropic substances
All types of inspectors (includes public
health officers, pharmaceutical inspectors)
Anti Counterfeit Act Prevent counterfeiting of medicines and
related commodities
All types of inspectors
Guidelines for Registration of Premises Outline minimum requirements for issuance
of wholesale and retail licenses
Pharmaceutical inspectors
Guidelines for Good Wholesaling
and Retailing Practice
Outline minimum requirements for the daily
operation of a retail or wholesale pharmacy
Pharmaceutical inspectors
Continuous Professional Development
points system
Assess practitioners for a minimum score
with regard to professional knowledge
Pharmaceutical Society of Kenya
Training Department
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The commonest causes of morbidity and mortality in
the region are malaria, diarrhoea, respiratory diseases, and
HIV/AIDS [25,26]. The two districts have similar socio-
economic status, with national statistics indicating that
51% and 54% of individuals live below the poverty line in
Bungoma and Kakamega, respectively (based on estimates
of expenditures on minimum food and non-food item re-
quirements) [27]. Both districts have at least one public
hospital and several private nursing homes and public
primary care facilities. As a result, over 90% of the
population lives within 5 km of a health facility (per-
sonal communication from KEMRI GIS Department
colleagues). However, the facilities suffer from low
staffing levels, with doctor-patient ratios of 1:26,613
(Bungoma) and 1:20,835 (Kakamega), way below the
WHO recommended figure of 1:1,000 [25,26].
Sampling and data collection procedures
Universal sampling was used, where all identified SDSs
were included in the study. Shops were identified through
a census, and data collected using an SDS survey. The
census was necessary because information held by the
health authorities on the numbers and location of SDSs
was likely to be incomplete and outdated. During the cen-
sus, shops were identified in 3 main ways; first, the field
team was recruited from the study areas, and was able to
identify some SDSs; second, local public health officers
(PHOs) were recruited as guides; and finally, staff working
in enumerated shops was asked to identify other shops
within the area.
Surveys were done between September and December
2009 by five trained field staff. Following verbal consent,
the SDS survey questionnaire, previously piloted outside
of the study areas, was administered to persons most in-
volved with day to day management of the shops. As SDSs
generally have staff with some formal education, the sur-
vey was administered in English. The survey tool covered
staff characteristics; location and structural features of the
premises; practice aspects such as the keeping of prescrip-
tion records; and the range of commodities stocked.
Specific regulatory behaviors were selected for investi-
gation using the following procedure. First, the diverse
legal and regulatory framework governing the pharma-
ceutical sector was mapped. This entailed identifying
relevant legislation and regulations from the medicines
regulatory authority (PPB), and guidelines from the pro-
fessional body representing pharmacy practitioners, as
summarized in Table 1. These regulations were then
classified as structure-related, equipment and material
requirements, and personnel and practice related regu-
lations. Two or three indicators were selected to repre-
sent each group, focusing on those that could be assessed
objectively by our field workers, without the need to make
subjective judgments or to observe consultations. Indica-
tors selected were: the building material for the premises,
and presence of a separate dispensing area to represent
structure; availability of a refrigerator, a narcotics cup-
board, and a prescription book to represent equipment
and materials; staff qualification and knowledge of the
name of the Pharmacy Act to represent personnel factors;
Table 2 Rules governing the retail pharmaceutical sector in Kenya
Area regulated Specific rules
Structure-related regulations ▪ → Premises must be registered
▪ → Annual premise license must be in place
▪ → Licenses must be displayed on the wall
▪ → Premises must comply with structural requirements for pharmacy practice:
- → Premises must have construction of permanent nature
- → Premises must be well lit and ventilated
- → Premises must have a separate dispensing area of minimum size 8 by 10 feet
- → Premises must have water, toilet facilities and lighting; proper storage area for medicines
Personnel and practice related regulations ▪ → Personnel must have proper qualification and registration
▪ → Annual practice license must be in place
▪ → Dispensing prescription medicines only with a valid prescription
▪ → Medicines sold must be properly labeled
▪ → Advertising of medicines and services not allowed without due permission
▪ → SDSs must not stock other household commodities alongside medicines
▪ → Records must be kept for the sale of prescription medicines
Equipment and materials related regulations ▪ → The premises should have basic equipment, including a refrigerator and a narcotics cupboard
▪ → The premises should have reference materials such as Martindale, reference showing
drugs available in the Kenyan market, and the Pharmacy and Poisons Act
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and displaying of licenses and stocking of other household
commodities to represent practice-related factors. We de-
cided not to assess validity of licenses, as we were con-
cerned that this could give the impression that the
interview was an inspection which could have damaged
rapport with the respondent and possibly exposed our
field staff to aggression, given the sensitivity of this area.
It was important that we did not threaten the rapport
with providers, as this study formed part of a larger
programme of work, involving a qualitative study of fac-
tors affecting regulatory compliance, drawing on in-
depth interviews with the same retailers [28]. Moreover,
inspecting a license does not in itself allow assessment
of SDS status as the named individual may not be in-
volved in day to day SDS operation.
We recognize that the regulations selected for the
study may not be reflective of public health importance,
and that other regulations with higher public health sig-
nificance may have been omitted for logistical reasons.
However, we also observe that the primary objective of
the study was to measure regulatory compliance, and
not the relative merit of different regulations.
Data management and analysis
Quality checks were made by a field supervisor and the
first author during data collection. Survey data were
double entered into MS Access 2007, and analysis was
conducted in Stata v11.0 (Stata Corporation, TX, USA).
The unit of analysis was the SDS for all variables. SDSs
operating within the main town were classified as urban,
and those located more than 3 km from the town classi-
fied as rural.
To compare SDS characteristics across districts and
urban/rural location, chi-square tests were performed. As-
sociations between selected regulatory practices and shop
and staff characteristics were explored using multivariate
analysis. The district and urban/rural location variables
were automatically included in the multivariate model be-
cause there were strong reasons a priori for expecting them
to be associated with regulatory practices. As regulatory
Figure 1 Map of Kenya showing study districts.
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enforcement is likely to be influenced by the district health
authority, it was expected that SDSs in the two districts
could vary depending on the nature and capacity of staff at
the district health office. Similarly, location was expected to
influence regulation, as rural SDSs have previously been
shown to offer lower quality of care in Kenya [24]. A step-
wise selection algorithm was applied to identify other vari-
ables for inclusion, with only those variables with a
univariate Wald test p-value of <0.2 being included [29,30].
Institutional ethical approval was provided by both
the KEMRI/Wellcome Trust Research Programme and
the London School of Hygiene and Tropical Medicine,
and national approval by the KEMRI National Ethical
Review Committee.
Results
Characteristics and regulatory practices of specialized
drug shops
A total of 130 and 94 shops were identified as oper-
ational in Bungoma and Kakamega respectively through
the census. The numbers in both districts were substan-
tially higher than expected based on projections from
previous work in the region, and on estimates provided
at the local health offices, which had indicated an esti-
mated total of 110 SDSs across both districts.
The medicine retailer survey was completed in 213 of
the 224 SDSs, with 11 (5%) refusing consent. The main
reason for refusal was the absence of the staff-in-charge.
Thirty SDSs were situated in urban locations in Bungoma
(25%), with Kakamega having 35 urban SDSs (38%). The
majority of SDSs had the owner working there (56 and
60% in Bungoma and Kakamega respectively).
Table 3 shows the regulatory characteristics stratified
by district and rural–urban location. Shops in the two
districts were similar with regard to qualification of staff,
displaying of licenses, and availability of a working re-
frigerator. Regulations that reported the lowest compli-
ance were the presence of separate dispensing rooms
and availability of narcotics cupboards and refrigerators.
Pharmacy qualified staff (pharmacists or pharmaceutical
technologists) were relatively few overall (43 and 51% of
SDSs in Bungoma and Kakamega), with the most com-
mon non-pharmacy cadre being nurse aides (54% of
SDSs) and nurses (33%). Nurse aides are trained on-the-
job to carry out a limited range of tasks, whereas nurses
have diploma or degree training in nursing, and offer all
nursing services. Nearly all shops reported having at
least one staff member with some health-related training
(defined broadly to include cadres such as nurse aides).
There were some differences between the districts, with
more shops in Kakamega having a separate dispensing
area compared to Bungoma (29 and 16% respectively,
p = 0.02), and more shops in Bungoma having prescription
recording books (48 and 33% respectively, p = 0.03).
Stratification by location showed urban shops to be bet-
ter regulatory compliers overall, with more shops having
separate dispensing areas, prescription recording books,
working refrigerators and at least one staff member with
pharmacy qualifications. More respondents in urban shops
also knew that the Pharmacy and Poisons Act was the
main legislation governing pharmacy practice in Kenya.
As far as inspections were concerned, little difference was
observed across the two locations or between districts,
with the proportion of shops reporting at least one regula-
tory visit over the last year being high overall (over 80% of
shops in both urban and rural locations and in both dis-
tricts). Varying the 3 km threshold for the definition of
“rural” in the analysis did not substantially change the allo-
cation of SDS between rural and urban categories, as most
‘rural’ SDSs were located in small trading centres located
10–60 km from the main town.
Predictors of regulatory practices of specialized
drug shops
We examined predictors of three regulatory compliance
outcomes, selected as tracers for regulatory practices
(keeping prescription records), equipment requirements
(availability of a refrigerator), and licensing requirements
(displaying licenses within premises) (Table 4).
Staff qualification was strongly associated with keeping of
prescription records, with shops having staff with a phar-
macy qualification having nearly 3 times the odds of keep-
ing the records compared to those without pharmacy-
qualified staff (adjusted OR 2.70, p = 0.004) (Table 4).
Unadjusted analysis also found shop location and staff
knowledge to be predictors for keeping of records
(p = 0.002 and p < 0.001 respectively), but both associations
weakened in the adjusted analysis (p = 0.050 and 0.060
respectively).
As noted above, availability of refrigerators was poor
across SDSs overall. However, important variations
emerged across shops. Adjusted analysis found strong
evidence linking availability of a fridge to shop location,
with shops in urban locations having 4 times the odds
of having a fridge (OR 4.23, p = 0.009). Pharmacy quali-
fication and knowing the name of the legislation gov-
erning pharmacy were also positively associated with
the outcome, and with displaying of licenses within the
premises (p = 0.03 and p < 0.001 respectively).
A common finding across the analysis of predictors
was the weak association between a regulatory inspec-
tion in the past year and regulatory compliance.
Discussion
This paper has presented data on regulatory practices of
SDSs in terms of a selected set of requirements stipulated
under the Kenyan legal and regulatory framework, and ex-
plored variation in regulatory compliance by location and
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other shop characteristics. Regulatory compliance was
poor overall, but especially across rural shops, where the
majority failed to meet requirements for staff qualification,
structure, premises and equipment.
Certain methodological limitations should be noted.
Although great care was taken to capture all shops by
using several complementary approaches, the possibility
that a few were omitted cannot be discounted. However,
the fact that we found over twice as many as estimated
by district health officers indicates that many of those
less likely to be on official records were identified by our
approach. Another potential source of bias is refusals;
while these were few overall (5%), one might expect
these shops to be less likely to comply with regulations.
There was also risk of reporting bias, especially on items
that could not be verified easily, for instance, staff quali-
fication. The need to prioritize indicators that could be
measured without making subjective judgments, observ-
ing consultations or raising suspicion that our staff were
inspectors limited the study’s ability to capture a com-
prehensive picture of regulatory compliance.
Caution is required when extrapolating findings to other
regions, as previous studies have shown the Western re-
gion to have high retail sector activity [31,32]. Addition-
ally, variations in the distribution of health facilities may
influence retailer behaviour. Previous work has shown the
Western region to have relatively good geographic access
to health facilities [17], which might be expected to influ-
ence client demand and thereby dispensing practices [24].
Key aspects of regulatory compliance documented by
this study include the finding that only 46% of SDS had
staff with a pharmacy qualification. Kenya, like many
other countries across the world, has a stringent licen-
sure system for individuals wishing to operate SDSs,
which includes 4 or 5 years pre-service training and a one-
year post-training internship for pharmacists, and three
years training for pharmaceutical technologists. Both cadres
also require a one-off professional registration by PPB, and
annual practice licenses for those practicing in their cap-
acity as pharmacists or technologists. This stringency is a
common characteristic in health care markets, and has
been a subject of debate over the years [33-35].
In Kenya, year 2008 estimates put the number of regis-
tered pharmacists and pharmaceutical technologists at
2,775 and 1,680 against an estimated population of 37.5
million [18], giving a ratio of one pharmaceutical staff to
8,417 people. The problem is exacerbated by the fact that
licensed individuals prefer urban locations, leaving the
rural areas with even fewer personnel. This explains why
staff without pharmacy qualifications were the main oper-
ators in rural SDSs. The predominance of nurse aides
staffing SDSs is likely to reflect their low marketability in
the formal health sector. Similar patterns have been ob-
served in Tanzania, where the majority of staff in private
drug stores were found to be nurse assistants [36].
As far as the structure of the premises and availability
of materials are concerned, the majority of shops lacked
a separate dispensing area, a refrigerator, a prescription
recording book, and a cupboard for keeping narcotic
and psychotropic substances. However, urban shops
were generally better regulatory compliers compared to
rural shops. Similar observations were made in Sri-Lanka,
Table 3 Regulatory characteristics of SDSs in the two districts (n = 213)
Total Districts Locations
n (%) Bungoma Kakamega p-Value Urban Rural p-Value
n (%) n (%) n (%) n (%)
Number of shops surveyed 213 120 93 - 65 148 -
Shop and staff characteristics
Premises made of bricks or stone 210 (99) 119 (99) 91 (98) 0.4 64 (98) 146 (99) 0.08
Shops with separate dispensing room 46 (22) 19 (16) 27 (29) 0.02 28 (43) 18 (12) <0.001
Shops selling household merchandise with medicines 50 (23) 26 (22) 24 (26) 0.5 13 (20) 37 (25) 0.4
Shops displaying any licenses on the wall 119 (56) 66 (55) 53 (58) 0.7 41 (63) 78 (53) 0.1
Shops with a pharmacy-qualified staff member1 99 (46) 52 (43) 47 (51) 0.3 39 (60) 60 (41) 0.009
Staff knows name of main law governing pharmacy2 64 (30) 33 (27) 31 (33) 0.4 33 (51) 31 (21) <0.001
Availability of materials and equipment
Shops with a prescription recording book 89 (42) 58 (48) 31 (33) 0.03 37 (57) 52 (35) 0.003
Shops with a working refrigerator available 25 (12) 13 (11) 12 (13) 0.6 18 (28) 7 (5) <0.001
Shops with a narcotics cupboard available 39 (18) 26 (22) 13 (14) 0.2 24 (37) 15 (10) <0.001
Frequency of regulatory inspection
Shops inspected within the last 12 months 182 (85) 104 (87) 78 (84) 0.6 58 (89) 124 (84) 0.3
1Includes pharmacists and pharmaceutical technologists, the two cadres recognized by the Kenyan law.
2Staff who could correctly name the ‘Pharmacy and Poisons Act’ as the main legislation governing pharmacy.
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Table 4 Univariate and multivariate analysis of predictors for selected regulatory practices (n = 213)
Keeping prescription records Availability of a working refrigerator Displaying licenses in premises
Predictor
variable
n (%) Unadjusted OR
(95% CI) p-value
Adjusted OR
(95% CI) p-value
n (%) Unadjusted OR
(95% CI) p-value
Adjusted OR
(95% CI) p-value
n (%) Unadjusted OR
(95% CI) p-value
Adjusted OR
(95% CI) p-value
District
Bungoma 42 (35) 1.09 (0.61-1.95)
p = 0.800
1.31 (0.69-2.50)
p = 0.400
13 (10) 0.82 (0.35-1.90)
p = 0.600
0.86 (0.30-2.47)
p = 0.700
66 (55) 0.89 (0.51-1.55)
p = 0.700
0.95 (0.52-1.74)
p = 0.900
Kakamega 30 (33) 12 (13) 53 (58)
Shop location
Urban 31 (50) 2.58 (1.37-4.86)
p = 0.002
1.94 (0.97-3.88)
p = 0.050
18 (28) 7.71 (2.86-20.77)
p < 0.001
4.14 (1.39-12.27)
p = 0.010
41 (63) 1.55 (0.84-2.85)
p = 0.200
0.99 (0.50-1.97)
p = 0.900
Rural 41 (28) 7 (5) 78 (53)
Licenses
displayed in
premises
Yes 49 (42) 2.19 (1.18-4.08)
p = 0.010
1.35 (0.69-2.67)
p = 0.300
23 (19) 10.66 (2.30-49.26)
p < 0.001
4.02 (0.81-20.10)
p = 0.090
- - -
No 22 (25) 2 (2) -
Pharmacy-
qualified staff
Yes 49 (50) 3.71 (1.96-7.00)
p < 0.001
2.70 (1.38-5.31)
p = 0.004
23 (23) 16.94 (3.53-81.20)
p < 0.001
6.21 (1.26-30.54)
p = 0.020
69 (70) 2.95 (1.63-5.34)
p < 0.001
1.95 (1.05-3.64)
p = 0.030
No 23 (21) 2 (2) 50 (45)
Knows name
of pharmacy
law
Yes 35 (55) 3.52 (1.84-6.71) 001 1.98 (0.95-4.10)
p = 0.060
21 (33) 17.70 (5.10-61.49)
p < 0.001
4.91 (1.33-18.12)
p = 0.010
51 (81) 4.94 (2.33-10.44)
p < 0.001
3.63 (1.67-7.89)
p < 0.001
No 37 (26) 4 (3) 68 (46)
Inspection in
the last year
Yes 62 (35) 1.05 (0.47-2.41)
p = 0.900
- 2.09 (0.46-9.44)
p = 0.300
- 105 (59) 1.72 (0.80-3.73)
p = 0.200
1.33 (0.59-3.01)
p = 0.500
No 10 (33) 23 (13) 14 (45)
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where the design and construction features of rural phar-
macies were found to be poorer than those of urban shops
[11]. A number of factors may explain why rural SDSs
were less likely to comply with structural and equipment
requirements, including lower capital injection in the busi-
ness, and lower stringency from regulatory inspectors dur-
ing rural visits, who may recognize that such rural shops
may not need to meet all these requirements if for in-
stance they do not sell narcotics, or medicines requiring
refrigeration [8,28].
Availability of refrigerators showed substantial vari-
ation across locations, with rural shops again performing
poorly compared to urban shops. However, the availabil-
ity of refrigerators was low overall (12%). Similarly, a
study in Malawi found three-quarters of practitioners
stocking and dispensing medicines without a refrigerator,
which was against the country’s regulatory requirements
[37]. In contrast, nearly all pharmacies in Sri-Lanka [11]
and Pakistan [38] were found to have refrigerators, with
the Sri-Lankan study reporting a 100% refrigerator avail-
ability among rural pharmacies [11]. The disparity across
countries in the 2 continents with similar regulatory re-
quirements may be a consequence of differences in
perceptions of the importance of specific regulations
(a refrigerator may be a more important regulatory marker
in South-East Asia than in Africa), or may simply be a
result of differences in the availability of electricity, or
differences in the levels of technological advancement
across the 2 regions.
Good regulatory compliance on the other hand, was re-
ported with regard to the nature of materials used in con-
structing premises, as well as refraining from stocking
non-medical commodities. Similar findings have been seen
elsewhere in SSA, with two-thirds of patent medicine ven-
dors (PMVs), and three-quarters of pharmacies selling
medicines and related commodities only in Nigeria and
Somaliland respectively [1,39]. A number of factors may
explain the preference for trading in medicines only, in-
cluding higher profits, insufficient capital to diversify, the
need to present a professional look, and strong competi-
tion in the market for non-medical commodities.
Less than a third of staff knew the name of the Phar-
macy and Poisons Act with nearly all staff who got the
name right working in urban locations. This is not unique
to Kenya; even worse results were seen in Tanzania where
only 3% of SDS owners, and 8% of dispensers knew the
name of legislation governing pharmacy practice [40]. This
raises two key questions: one, can providers comply with
provisions of a regulation whose identity they do not ap-
pear to know? Two, what do regulatory visits entail? Are
regulators required to explain the legal basis for inspec-
tions during regulatory visits, and do they?
The majority of shops reported having received at least
one regulatory visit over the past year, a frequency that
was similar to that reported in a separate assessment
conducted in Nairobi [18]. Frequency of regulatory visits
varied across Sub-Saharan African countries, with only a
third of PMVs in Nigeria reporting visits over the last
2 years, while the majority of drug shops in Tanzania
had received visits over the last year [41,42]. Where in-
spection frequencies were low, lack of human and finan-
cial resources was commonly cited as the reason [43,44].
Although the relationship between frequency of inspec-
tions and regulatory compliance has rarely been studied
in low-income settings, lower inspection frequencies are
often blamed for poor regulatory compliance [45]. How-
ever, this was not the case in this study.
It is worth noting that not all practices showed varia-
tions across locations. The practice of displaying licenses,
for instance, did not vary significantly across rural (53%)
and urban areas (63%). Low compliance to similar regula-
tory requirements has also been reported in Tanzania,
where only a third of shops were found displaying the
Pharmacy Board permit, and in Sri-Lanka, where 57% did
not display licenses as required by law [11,42].
Aside from location, staff qualification was an import-
ant predictor of regulatory compliance. Shops with
qualified staff were more likely to display licenses, and
have prescription records and a refrigerator. Besides
bearing a strong association with displaying of licenses,
knowledge of the name of the Pharmacy and Poisons
Act was associated with availability of a working refriger-
ator and the practice of keeping prescription records.
One would also expect licensed pharmacies to be more
compliant but a significant association was not found
keeping prescription records or having a working re-
frigerator. This could reflect the limitations of this indi-
cator as a proxy for having a valid licence. It is likely
that some displayed licenses were outdated, or belonged
to individuals not involved in the day to day operation
of the business. On the other hand, some SDS without
displayed licenses were said by the PPB to be in the
‘registration process’, and could therefore neither be clas-
sified as registered or unregistered.
A number of policy questions emerge from the study.
First, are all the regulations relevant for all SDSs in
terms of their impact on public health and safety? For
instance, is a refrigerator necessary for an SDS stocking
medicines that do not require refrigeration? Is a nar-
cotics cupboard necessary for an SDS not stocking nar-
cotics, given that this is very rare in rural areas [46]? Is
it really detrimental to health outcomes to stock a wider
range of commodities beyond those that are medically-
related? While these regulations are considered ideal for
SDSs offering comprehensive pharmacy services, some
may not be relevant for those offering a limited range of
commodities, especially those in remote areas with low
business potential.
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In addition, SDSs operating in such areas are unlikely to
attract staff with pharmacy qualifications, whose numbers
are generally low in Kenya and other Sub-Saharan African
countries as described above. This therefore raises the
question of whether certain non-pharmacy cadres such as
nurses or even nurse aides can be legally allowed to op-
erate SDS in resource poor settings in order to main-
tain some access to medicines where there are few
other reliable sources.
These questions suggest the need for considering
“levels of practice” in the retail pharmaceutical sector in
Kenya, that recognize resource-constraints and low busi-
ness activity for operators working in remote areas.
Under such a system, a lower level of SDS can be li-
censed by the medicine regulator to provide a limited
range of medicines while being operated by individuals
with some health-related training, and meeting a set of
regulations appropriate to their product mix. This will
require action by Kenyan stakeholders to discuss and
identify practices and regulations for each level, involv-
ing reflection on the public health importance of each
regulation. Such a system would require practice areas to
be well-defined to avoid compromising the governance of
pharmaceutical staff-operated SDSs in more urban loca-
tions, and to ensure that such lower level practices are
only permitted in areas with access problems to alternative
facilities. Already, countries like Tanzania, Ghana and
Nigeria are implementing system of levels of practice for
instance through the accredited drugs dispensing outlets
(ADDOs) in Tanzania, licensed chemical sellers in Ghana,
and patent medicine vendors in Nigeria [47-49]. The po-
tential benefits of such a system are that it encourages
rural operators to seek legitimization, and subscribe to
agreed minimum standards, rather than either remaining
unlicensed and unregulated. It also avoids a situation
where there is routinely a high level of discordance be-
tween regulatory standards and implementation, which
provides high potential for corruption. Qualitative work
with SDS and regulatory inspectors demonstrated that the
current discordance led to routine payment of bribes and
great uncertainty for SDS operators [28].
Future research should explore ways of collecting infor-
mation on regulatory factors that involve interaction with
clients, particularly those that link directly to patient safety.
This would require identifying aspects of regulation that
can be measured using direct observation of operator-
client interactions or use of mystery shoppers, which have
been widely used in assessing ‘quality of care’ and some as-
pects of regulatory compliance [24,50-52]. Studies should
also examine knowledge of regulations in greater depth to
gauge the degree to which non-compliance with regulation
reflects poor knowledge or discordances between know-
ledge and practice, thereby showing the degree to which
educational interventions would potentially be beneficial.
Also required, is an in-depth understanding of the relation-
ship between regulatory enforcement and the regulatory
practices observed. This paper showed that regulatory
compliance was poor, despite SDSs receiving regulatory
visits. Future work should explore why compliance remains
poor despite frequent regulatory inspections.
Conclusion
The study set out to describe regulatory compliance
among specialized drug shops in Kenya, and assess pat-
terns of association between regulatory practices and se-
lected predictors. Regulatory compliance was poor overall,
but especially across rural shops, where the majority failed
to meet requirements for staff qualification, structure,
premises or equipment. Although regulatory inspections
were common across both rural and urban locations,
compliance was not influenced significantly by the fre-
quency of such visits.
The poor regulatory compliance, particularly among
rural operators, suggests a need for alternative approaches
to regulating SDSs. Policymakers need to reexamine the
list of regulations and decide whether all requirements
should apply across the board, or whether regulatory re-
quirements should be linked to the scope of practice and
the location of the practice. Such an approach may reduce
the number of SDSs operating unlawfully, and allow more
shops to seek formal registration. Future research should
focus on understanding reasons for poor regulatory com-
pliance, especially among rural operators, despite what ap-
pear to be high frequencies of regulatory inspection.
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